You just read:

Tocagen and NRG Oncology to Collaborate on a Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma

News provided by

Tocagen Inc.

Nov 29, 2018, 08:00 ET